• Eli Lilly and HCL opens IT Co-Innovation Lab in Singapore.
• The lab will leverage technology to support Eli Lilly's global IT innovation agenda to improve patient outcomes and bring novel solutions to the market to support Eli Lilly's global customer base.
Eli Lilly, a global pharmaceutical corporation and HCL Technologies Ltd. (HCL), a leading global IT services provider, today announced the opening of a Co-Innovation Lab in Singapore for developing novel technologies and improve operational efficiencies to enhance Eli Lilly’s global competitiveness.
This unique collaboration, the first globally for both companies, will accelerate the process of bringing ideas to fruition by leveraging this Co-Innovation lab and HCL’s wider collaborative Ecosystem, using new disruptive technologies and solutions, and through rapid development of Proof of Concept (PoCs).
The two companies will establish a collaborative framework for incubating innovative ideas and concepts based on tangible business needs. They will track technology trends and create PoCs for applied solution frameworks. Learning will be taken from multiple industries including: banking, government, insurance, manufacturing, telecom as well as pharmaceuticals. HCL will leverage state-of-the-art technologies such as: cloud computing, automation, business analytics, enterprise mobility etc. combined with its domain expertise in numerous areas to create innovative applications and solutions to support Eli Lilly’s global operations. Co-Innovation will help the two companies to extend the scale and scope of external partnerships and alliances. These will then, in turn, bring new ideas in the form of technology and knowledge to the market.
The laboratory, which will act as a key component of Eli Lilly’s IT Innovation strategy, was inaugurated by Michael C. Heim, Senior Vice President and Chief Information Officer, Eli Lilly and Company.
“We are delighted to launch this Co-Innovation Lab with HCL which will serve as a center for our company’s efforts to leverage IT to create competitive differentiators for our business. HCL’s domain expertise in the pharmaceutical industry and excellent track record in IT transformation make them an ideal partner on this journey, which we believe will ultimately bring benefits to the patients we serve” said Michael C. Heim.
The HCL-Eli Lilly Co-Innovation Lab will be housed in a 35000 sq ft dedicated space in HCL’s Jurong Development Center in Singapore and bring together a diverse set of partners and local/global talent to ensure a swift pursuit of business-aligned IT solutions. HCL, which already has over 1,000 engineers based out of the facility, will work closely with the government of Singapore to ensure the lab becomes a global hub of IT innovation in the pharmaceutical industry. The Lab will also be front-ending a close collaboration with educational and academic research centers across the globe to meet these objectives.
Speaking on the occasion of the formal opening of the facility, Mr. Virender Aggarwal, President and Head of APAC- MEA region for HCL said,“We want to thank Eli Lilly for the trust reposed in us. We have partnered very closely with Eli Lilly over the last several years, beginning with highly successful collaborations in the Emerging Markets and Japan, which have been leveraged as centres of technology innovation by Piers Shore, Vice President, Information Technology, Eli Lilly and Company. This Co-Innovation Lab will accelerate the pursuit of innovation led transformation by providing a collaborative environment and systematically cultivate new ideas and possibilities for Eli Lilly. We are confident that our proven experience in healthcare and pharmaceutical industry and globally acknowledged reputation in IT innovation will ensure that this lab becomes a benchmark in business value generation,” he added.
HCL has also opened a Global Enterprise Mobility Lab recently in Singapore and continues to invest in the country in light of its excellent infrastructure, supportive government policies, availability of highly skilled talent pool and high concentration of global MNCs and premier educational institutions.
About HCL Technologies
HCL Technologies (hcltech.com) is a leading global IT services company, working with clients in the areas that impact and redefine the core of their businesses. Since its inception into the global landscape after its IPO in 1999, HCL focuses on ‘transformational outsourcing’, underlined by innovation and value creation, and offers integrated portfolio of services including software-led IT solutions, remote infrastructure management, engineering and R&D services and BPO. HCL leverages its extensive global offshore infrastructure and network of offices in 26 countries to provide holistic, multi-service delivery in key industry verticals including Financial Services, Manufacturing, Consumer Services, Public Services and Healthcare. HCL takes pride in its philosophy of ‘Employee First’ which empowers our 73,420 transformers to create a real value for the customers. HCL Technologies, along with its subsidiaries, had consolidated revenues of US$ 3.3 billion (Rs. 15,160 crores), as on 31 March 2011 (on LTM basis).
HCL (hcl.com) is a $5.9 billion leading global technology and IT enterprise comprising two companies listed in India - HCL Technologies and HCL Infosystems. Founded in 1976, HCL is one of India's original IT garage start-ups. A pioneer of modern computing, HCL is a global transformational enterprise today. Its range of offerings includes product engineering, custom & package applications, BPO, IT infrastructure services, IT hardware, systems integration, and distribution of information and communications technology (ICT) products across a wide range of focused industry verticals. The HCL team consists of over 80,000 professionals of diverse nationalities, who operate from 31 countries including over 500 points of presence in India. HCL has partnerships with several leading global 1000 firms, including leading IT and technology firms.
Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward looking statements, including but not limited to the statements containing the words 'planned','expects','believes’, ‘strategy','opportunity','anticipates','hopes' or other similar words. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, fluctuations in earnings, our ability to manage growth, intense competition in IT services, BusinessProcess Outsourcing and consulting services including those factors which may affect our cost advantage, wage increases in India, customer acceptances of our services, products and fee structures, our ability to attract and retain highly skilled professionals, our ability to integrate acquired assets in a cost effective and timely manner, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, the success of our brand development efforts, liability for damages on our service contracts, the success of the companies /entities in which we have made strategic investments, withdrawal of governmental fiscal incentives, political instability, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property, other risks, uncertainties and general economic conditions affecting our industry. There can be no assurance that the forward looking statements made herein will prove to be accurate, and issuance of such forward looking statements should not be regarded as a representation by the Company, or any other person, that the objective and plans of the Company will be achieved. All forward looking statements made herein are based on information presently available to the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.